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      ABSTRACT 
 
NITROOLEFIN FUNCTIONALIZED BODIPY DYES 
FOR PROTEIN LABELING 
 
 
 
Hatice Turgut 
 
M.S. in Material Science and Nanotechnology 
Supervisor: Prof. Dr. Engin U. Akkaya 
       January,  2013 
 
Protein labeling has significant importance in terms of visualizing dynamics of 
proteins, cell-cell interactions, mechanisms of life cycles of proteins, etc. Proteins 
are labeled by either synthetic or natural molecules with purposes such as analysis 
of 3D structures, determination of turnover number, covalent modifications and 
tracking protein-protein interactions. In addition to this, sensing and signalling 
thiol groups have gained popularity recently. Nitroolefin groups on dyes are good 
Micheal acceptors which undergo fast and selective reaction with thiol moieties. 
With this knowledge, in this study, we aimed to obtain derivatives of BODIPY 
dyes having nitroolefin substituents on its different positions. Nitroolefin 
functionalization of BODIPY dyes was targeted to result in conjugation of 
nitroolefins with thiol groups such as those belonging to cysteine residues on 
proteins. Three different nitroolefin functionalized BODIPY dyes have been 
designed, synthesized and characterized successfully. Incorporating triethylene 
glycol (TEG) units onto BODIPYs increased water-solubility of the molecules. To 
prove bioconjugation of the dyes with proteins, absorbance and emission changes 
were recorded after reaction with both L-cysteine and Bovine Serum Albumin 
(BSA) and large spectral changes were obtained. The result suggests that 
nitroolefin functionalization of BODIPY dyes is a promising way to sense 
biological thiols and hence labeling proteins having thiol groups.  
 
Keywords: BODIPY, protein labeling, nitroolefin, thiol, cysteine, Bovine Serum 
Albumine (BSA), dialysis  
 
iii 
 
   
       ÖZET  
 
PROTEİN ETİKETLEME AMAÇLI 
NITROOLEFIN FONKSIYONLANDIRILMIŞ BODIPY BOYALARI 
 
    
      Hatice Turgut 
 
               Yükek Lisans, Malzeme Bilimi ve Nanoteknoloji Programı 
                                   Tez Yöntecisi: Prof.Dr. Engin U. Akkaya 
        Ocak, 2013 
 
Protein etiketleme, protein dinamiklerini gözlemleme, hücrelerin birbirleriyle 
etkileşimleri, proteinlerin yaşam döngülerinin mekanizmaları ve benzeri konular 
açısından oldukça önem taşımaktadır. Proteinler, yapay veya doğal moleküllerle, 
3 boyutlu yapı analizleri, kovalent modifikasyonlar, protein-protein etkileşimlerini 
belirleme, devir sayısı tayini gibi amaçlarla etiketlenirler. Buna ek olarak, tiyol 
gruplarının algılanması ve sinyalizasyonu da son zamanlarda popülerlik 
kazanmıştır. Boyaların üzerindeki nitroolefin grupları, tiyol gruplarıyla hızlı ve 
seçici reaksiyon veren iyi Micheal akseptörleridir. Bu bilgiye dayanarak, bu 
çalışmada, değişik pozisyonlarında nitroolefin bulunan BODIPY türevleri elde 
etmeyi hedefledik. BODIPY boyalarının nitroolefin fonksiyonlandırılmasında, 
nitroolefin gruplarının proteinlerin üzerindeki sistein gibi tiyol içeren gruplarla 
konjugasyon yapmasını amaçladık. Üç farklı nitroolefin fonksiyonlandırılmış 
BODIPY boyaları başarıyla dizayn edildi, sentezlendi ve karakterize edildi. 
BODIPY üzerine trietilen glikol ünitelerinin eklenmesi de bu moleküllerin suda 
çözünülürlüğünü artırdı. Boyaların proteinle biyokonjugasyon yaptığını 
kanıtlamak için, hem L-sistein hem de Bovin Serum Albumin (BSA) ile boyaların 
reaksiyonu sonrası absorbans ve ışıma değişimleri kaydedildi ve spektral 
karakteristiklerde geniş değişimler elde edildi. Sonuçlar, BODIPY boyalarının 
nitroolefin fonksiyonlandırılmasının, biyolojik tiyollerin algılanması ve 
dolayısıyla üzerinde tiyol grupları bulunduran proteinlerin etiketlenmesi açısından 
gelecek vaad eden bir yol olduğunu göstermektedir.   
 
Anahtar Kelimeler: BODIPY, protein etiketleme, nitroolefin, tiyol, sistein, Bovin 
Serum Albumin(BSA), dializ  
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CHAPTER 1 
 
INTRODUCTION 
 
 
1.1 Protein Labeling  
 
Proteins belong to a class of major biomolecules existing in all living species. 
Their functions and interactions affect the whole organisation of the life. The term 
“protein labeling’’ stands for marking proteins to follow their mechanisms. 
Protein labeling has great biological importance in terms of visualizing cell-cell 
interactions, dynamics of proteins, mechanisms of life cycles of proteins, etc. The 
characterization of proteins in complex mixtures, as well as analysis of their 
biosynthesis, processing, intracellular mechanisms and degradation, generally 
requires the proteins to be labeled either in vivo or in vitro. Labeled protein is then 
isolated and analyzed by electrophoretic techniques
1
.  
Labeling strategies include covalent or noncovalent attachment of the label to the 
target and since it is specific to the process, the strategy should be considered 
carefully in order not to disrupt the structure of the molecule. There are some 
factors affecting the choice of labeling strategy: Some proteins are affected 
negatively from fusion to another protein or peptide, some techniques are only 
suitable to surface proteins and others are for intracellular ones, different 
applications require different probes, techniques using disulfide bridges are 
influenced by the redox condition of the cell, etc.
2
.   
 The purposes of protein labeling includes lowering detection limits, obtaining 
turnover number, covalent modifications, analysis of 3D structures (Structure 
determination by NMR via radioactive labelling) and protein-protein interactions, 
immunological tests, affinity tests by nonradioactive labeling
2
. 
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1.1.1 In vivo labeling  
Metabolic labeling is a strategy to label nucleic acids or proteins in a cell by 
culturing them with labeled nucleotides or amino acids. Cell culture in media 
containing labeled nucleic acids or amino acids results in all DNA, RNA or 
proteins becoming labeled via DNA replication, translation and protein turnover. 
The nucleic acid or protein of interest can later be purified for further 
experiments. The advantage of performing metabolic labeling is the consistent 
labeling of all nucleic acid or protein species. On the other hand, metabolic 
labeling can be toxic, depending on the type of label used, and the number of 
metabolic labeling reagents is not as broad as those for in vitro methods
3
. 
Protein labeling with fluorescent probes or affinity reagents has facilitated in vitro 
studies of protein structure, dynamics and interactions of them with each other
4
. 
Since these traditional methods require purification of protein, chemical labeling, 
repurification and some invasive methods such as microinjection to reintroduce 
into cells, they are not adequate for in vivo studies. The general strategy of in vivo, 
site-specific protein labeling is summarized in figure 1. 
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 a) Living cells are transfected with        
DNA encoding a protein of interest 
which is fused to a receptor domain 
b) a cell-permeable small molecule 
probe consisting of a ligand coupled 
to a detectable tag is added to cell 
growth medium c)Analysis of protein 
function in living cells via fluorescent 
microscopy or other detection 
methods.  
 
 
There are both direct and indirect approaches to chemically modify proteins in 
vivo
5
. 
Most of the methods of in vivo labeling depends on ligand-receptor interactions. 
General ligand-receptor pairs include biotin-avidin system, hapten-antibody, 
various enzyme-antibody combinations, nitrilotriacetate(NTA)-oligohistidine 
sequence, biarsenical fluorophores that bind to cysteine-rich peptide sequences
5
. 
The biarsencial ligand/tetracysteine motif interaction studied by Roger Tsien's 
laboratory is the prototypical system for the specific chemical labeling of proteins 
in vivo (Figure 2a)
6-10
. This strategy depends on the subnanomolar affinity 
between a short tetracysteine peptide (CCXXCC, where X is any amino acid 
except cysteine) and a biarsenical compound such as 4′,5′-bis(1,3,2-dithioarsolan-
2-yl)fluorescein (FlAsH)
5
. In this method, the FlAsH dye is administered to the 
cells in the presence of an excess of 1,2-ethanedithiol (EDT) which outcompetes 
   
Figure  1: General strategy of in vivo, site-specific protein labeling. Picture 
 adapted from ref 5 with permission. Copyright © 2012 Copyright Clearance 
 Center, Inc. 
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endogenous proteins with closely spaced cysteine pairs. Therefore it minimizes 
non-specific binding and toxicity. The target protein of interest is expressed with 
the tetracysteine motif
5
. Besides the green FlAsH biarsenical, red (ReAsH)
8
,  blue 
(ChoXAsH), and a biarsenical derivative of nile red have been synthesized
11
. In 
addition to direct chemical labeling, indirect approaches for modification of 
proteins also exist. Specific incorporation of unnatural amino acids based on 
suppressor tRNA technology
12-14
 is one of these. Protein splicing
15-17 
technique 
has also been adapted to protein labeling. 
 
 
 
 
Figure  2: Some methods of labeling fusion proteins chemically in vivo 
 (a) FlAsH. Binding of a biarsenical fluorescein derivative to a short tetracysteine 
peptide fused to the protein of interest (POI) (b) Human O6-alkylguanine DNA 
alkyl transferase (hAGT) is labeled covalently with benzyl guanine 
derivatives. (c) Schematic representation of methotrexate-Texas Red™ dye bound 
to an E. coli dihydrofolate reductase (eDHFR) protein. (d) Split intein labeling
5
. 
Picture adapted from ref 5 with permission. Copyright © 2012 Copyright 
Clearance Center, Inc. 
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1.1.2 In vitro labeling  
 
Chemical methods of protein labeling include the covalent attachment of labels to 
amino acids in laboratory environment. These groups, react with specific moieties 
on distinct amino acids. A few are also available that nonspecifically react with 
any amino acid at C-H and N-H bonds. Enzymatic methods are also used to label 
proteins and nucleic acids. These methods require the related polymerases, ATP 
and labeled amino acids or nucleotides. The expression of labeled proteins by in 
vitro translation can be difficult due to the requirement for proper protein length, 
folding and post-translational modifications that some commercial kits are unable 
to provide
3
. 
1.1.2.1 Protein Labeling Procedure  
 
Firstly, dye & protein solution is prepared. For lysine-sensitive labeling, pH 
should be greater than 8; for cysteine-directed labeling,  pH should be around 7 
and concentration greater than 50 µm is acceptable. Then conjugation reaction 
takes place by stirring, under protection from light and careful monitoring 
considering time and temperature. To remove excess dye; gel filtration, HPLC, 
dialysis or precipitation is done. For characterization of the conjugate, absorbance, 
fluorescence spectra could be obtained or mass spectroscopy could be useful in 
order to determine concentration, labeling ratio, label attachment site(s). Lastly, 
for biological testing, SDS, native gel denaturation experiments, etc. could be 
performed
2
.  
 
1.1.3 Bioconjugation  
Bioconjugation is the process of coupling two biomolecules via a covalent bond. 
Amine coupling of lysine amino acid residues, sulfhydyrl coupling of cysteine 
residues and photochemically initiated free radical reactions are common types of 
bioconjugation reactions. The product of bioconjugation is named as 
6 
 
“bioconjugate’’. Coupling of a small molecule such as biotin or a fluorescent dye 
to a protein or protein-protein conjugation such as antibody-enzyme conjugation 
are very common reactions of this type. Other less common molecules used in 
bioconjugation are oligosaccharides, nucleic acids, synthetic polymers such as 
polyethylene glycol
18
.  
 
1.2 Protein Labeling Techniques and Probes  
 
Various probes and techniques exist in the literature that are useful in a number of 
areas such as chemical, biochemical analysis, biotechnology and 
immunodiagnostics in terms of protein labeling
19
. 
 
1.2.1 Chemical Labeling Techniques  
There exists both covalent and noncovalent techniques to label proteins. In 
covalent techniques, chemical bonds are formed between the label and the protein 
whereas in noncovalent methods, there occurs a noncovalent interaction between 
the label and the target. 
1.2.1.1 Covalent Labeling  
One method to label cell-surface proteins is the ACP-PPTase system
20
. In this 
system, acyl carrier protein (ACP) undergoes post-translational modification by 
phosphopantetheine transferase (PPTase) as depicted in figure 3 which provides 
the transfer of 4′-phosphopantetheine from coenzyme A(CoA) to a serine residue 
of ACP
21
. This system is not commonly used to make labeling in living cells due 
to the activity of endogenous enzymes, limitation to cell-surface proteins and 
difficulty of cell permeability of the probes
20 
.  
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Figure  3: Labeling of ACP proteins on cell surface  Picture adapted with 
permission from reference 22. Copyright © 2004, American Chemical Society 
Secondly, biotin ligase has been used to covalently label a short, acceptor peptide 
which can react with hydrazide or hydroxylamine fluorescent dyes
23
 and this 
technique could be used to biotinylate cell-surface proteins for labeling with 
streptavidin conjugates
24
 
Another covalent labeling system depends on self alkylation reaction of human 
O
6
-alkylguanine transferase ( hAGT) to label hAGT fusion proteins with a type of 
fluorescent O
6
-benzylguanine substrates
25,26 
as depicted in figure 4. 
 
 
 
Figure  4: Covalent labeling techniques. hAGT system uses the enzyme activity 
to conjugate molecules containing both the label and the enzyme’s substrate20 
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1.2.1.2 Noncovalent Labeling  
 
There exists several noncovalent techniques which do not include endogenous 
enzymes or substrate problems faced in covalent ones. Tetracysteine-bioarsenical 
system that uses a nonendogenous, high affinity system is one of them. There is 
interaction between the enzyme dihydrofolate reductase (DHFR) and 
methotrexate to label DHFR fusion proteins by using a Texas-Red conjugate of 
methotrexate
27
. An improved system including bacterial DHFR and trimethoprim 
derivatives has also been published as shown in the figure 5. 
 
 
 
Figure  5: Schematic representation of TMP-eDHFR labeling system 
TMP is covalently attached to a fluorescent tag and bound by a chimeric fusion to 
eDHFR. Fluorescent TMP rapidly diffuses into mammalian cells when added into 
the culture medium. The orthogonal interaction of TMP–eDHFR creates specific 
fluorescent labeling of the protein. Picture adapted from reference 28 with 
permission. Copyright © 2007 WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim 
   
 
A single-chain antibody (scFV) that binds to a fluorescein conjugated hapten 
constitutes a specific receptor-ligand pair
29 
. In this process, the protein is labeled 
on the secretory pathway and provides the estimation of pH in the endoplasmic 
reticulum (ER) but as a disadvantage, the single-chain antibodies fold poorly in 
9 
 
the cytosol
29
. Nitriloacetate ligands that bind reversibly to short endogenous 
oligohistidine sequences (NTA-His system) have been applied more recently. 
These ligands, however, are very weakly fluorescent; they have very low quantum 
yield though they absorb photons efficiently. Consequently, they could be 
accepted as good FRET acceptors which is a property used to map the binding site 
of a fluorescent serotonin receptor antagonist
30
. Furthermore, other peptide-ligand 
pairs created by phage display selection of peptides that have the ability to bind to 
Texas red derivatives and can be used for labeling of fusion proteins have also 
been developed
31,32
. Since Texas-red based dyes can accumulate in mitochondria, 
it may cause nonspecific binding. Another approach useful to overcome 
nonspecificity has been proposed. In this approach, a mutant of FK-binding 
protein 12 (FKBP12 (F36V) ) binds to a fluorescent ligand which has a very high 
affinity towards it and this prevents binding of endogenous proteins endangering 
many chemical labeling techniques. The method has been used in many different 
cells by using different FKBP12 proteins and proved as efficient
33
. 
 
Figure  6: Non-covalent labeling techniques. A ligand binds specifically to a 
moiety which is conjugated to the target protein
20
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1.2.2 Biological fluorophores 
 
Phycobiliproteins are in this category. They are complexes purified from 
cyanobacteria and algae. They are highly soluble in water, have large Stokes 
shifts, very intense emission of light, broad and high absorption of light. R-Phyco-
Erythrin and C-Phyco-Cyanine are some examples
34
. 
Green Fluorescent Protein(GFP) is the major natural protein that is useful in 
protein labeling. It was first isolated from Aequorea Victoria jellyfish 
(Shimomura,1962)
35
 and Tsien’s research group has published many 
developments and they contributed to many other discoveries about GFP
36-42
. 
Shimomura, Tsien and Chalfie were Nobel prized for their study about GFP
43
.  
Though GFP has a highly efficiently emitting fluorophore with high-resolution 
crystals and it is useful as a marker of gene expression and protein targeting
44 
it is 
also claimed that since GFP and GFP-like molecules (FPs) are bulky, they are 
restricted due to their oligomeric structure and they may be harmful to the 3D 
structure of the protein to which they are linked
45
. 
 
 
 
 
Figure  7: The Green Fluorescent Protein
46 
 
1.2.3  Luminescence probes for proteins  
11 
 
 
Luminescent probes have been widely used for protein labeling applications. 
Noncovalent fluorescent probes, near-IR fluorescent probes, Fluorescent 
derivatizing reagents reacting with protein at the N-terminus, rare earth ions 
together with their chealetes, chemiluminescence probes , resonance light 
scattering probes, nanoparticles and molecular beacons (MBs) are in this 
category
19
. 
 
Fluorescent probes are very useful for labeling due to having the following 
features: High molar absorbance, high photostability, large Stokes shifts, excellent 
solubility and stability in water and/or organic solvents, choice to cover visible 
and far red spectrum, available as free acid form, amine- and thio-reactive 
derivatives. Free carboxy group could be conjugated to amine groups on proteins, 
maleimide groups are able to be conjugated to thiol groups and succinimidyl 
esters are available for amino groups on proteins, DNA, RNA
34
. 
 
There are both covalent and noncovalent probes for protein detection. Dyes used 
as noncovalent probes are generally anionic dyes. These can bind to the residues 
of proteins carrying positive charges and pH is thus important
19
. Nile red
47
 and 
Sypro dyes
48
 are typical dyes in this category.   Fluorescence quenching of dyes 
can also be used for protein detection
19
. For instance, Eosine Y gives strong 
fluorescence at pH 3.1 which is quenched after binding to proteins which could be 
used to detect proteins at a level of 1-100 µg
49,50
. 
 
 
Figure  8: Structure of Nile Red 
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Fluorescence in near infrared region (600-1000 nm) is advantageous over 
ultraviolet and visible regions
19
. Low levels of background interference, reduced 
scatter, reduction in sample photodecomposition when longer wavelengths are 
used, excitation by cheap, stable, and compact diode lasers, ability to penetrate 
through the skin and tissues are some properties that could be observed in 
NIR
51,52
. NIR dyes have good photopysical properties such as high quantum yield, 
large Stokes shift, high molar absorptivity. There are three types of dyes in this 
category recorded in the literature
19
 which are namely, Cyanine dyes
53-56
, 
Squaraine dyes
57,58
, Thiazine and Oxazine derivatives
59,60
. 
Proteins have both N-terminus and C-terminus. Since C-terminus is not very 
active, it is not used in labeling applications very often. Only proteins having Phe 
and Trp are known to exibit natural fluorescence and the others should be 
derivatized or labeled by some reagents. Since N-terminus is more reactive, there 
exists many fluorescent derivatizing reagents reacting with proteins at the N-
terminus
19
. Ninhydrin
48,49
, fluorescein-5-isothiocyanate(FITC)
63,64
, naphthalene-
2,3-dialdehyde/cyanide (NDA)
65
 are some of the reagents used in this category. 
 
Figure  9: Structure of Ninhydrin 
Rare earth ions, due to having luminescence characteristics such as narrow 
spectral width, large Stokes shift, long luminescence lifetime, etc. and comparable 
sizes to inorganic cations Ca
2+
 and Mg
2+
 are used as probes for proteins. Since 
they may have low sensitivity themselves, some rare earth ions (especially Eu
3+
 
and Tb
3+ ) are more useful when bound to chelates such as β-diketone19.  
Phenantroline derivatives
66
 and salicyclic acid derivatives
67
 are in this category. A 
phenantroline derivative, namely, 4,7-bis(chlorosulfophenyl)-1,10-phenantroline-
2,9-dicarboxylic acid (BCPDA) was a good chelator of Eu
3+
 and it was used to 
label BSA
68
. 
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Figure  10: Structure of phenantroline derivatives 
 
Resonance light scattering(RLS) is a phenomenon of elastic-light scattering
19
. 
RLS intensity of some organic compounds can be increased by biopolymers or 
inorganic ions due to supramolecular aggregations and some reactions and thus, 
the application of RLS could be used for detection of proteins
19
. Proteins are 
positively charged when pH is below their isoelectric point(PI) and they are more 
prone to aggregation on acidic dyes. Consequently, RLS intensity of dyes could 
be enhanced by the addition of proteins
19
. Porphyrins
69-73
 and acidic dyes are 
under the heading of organic dyes in this phenomena. Anion surfactants, dye-
nonionic surfactants and resonance double scattering method are the other  tools 
used for detection of proteins depending on RLS method
19
.  
 
 
Figure  11: Structure of the simplest porphyrin 
 
Chemiluminescence is another phenomenon which is made use of for detection of 
proteins. When a molecule relaxes to the ground state from an excited state, it 
14 
 
emits light which is called ‘’luminescence’’. If the energy to obtain the excited 
state is gained by a chemical reaction, it is called ‘’chemiluminescence’’74. 
Derivatization of proteins with a chemiluminogenic label could be used for 
labeling applications. Acylhydrazides, acridinium derivatives, dioxetanes, 
coelenterazines and peroxyoxalic derivatives are the five classes utilized as 
chemiluminescent probes
19,75
. 
 
Molecular beacons
76
 and nanoparticle probes are the other types used as for 
protein detection. Nanoparticle probes could be subdivided as latex nanospheres
77
, 
luminescent quantum dots (Qdots) (semiconductor nanocrsytals)
78,79
 and optically 
active metal nanoparticles
80
. Though nanorparticles have unique physical and 
chemical properties especially useful for analytical chemistry, their application is 
still developing and will offer new oppurtuinites in the future
19
. 
 
1.2.4  Biotin and Enzymes  
 
When one of the groups or molecules of the two having high affinty towards each 
other is attached to a protein, the other affinity partner makes it possible to detect 
the protein. The best technique with this purpose is the biotinylation of proteins
2
. 
Biotin is an indirect label which is popular due to is versatility for detection, 
purification, and amplification systems
34  
and its extraordinarily strong binding to 
avidin, streptavidin or NeutrAvidin Protein
3
. It offers one of the strongest non-
covalent interactions between a protein and a ligand and stands for one of the 
most compatible labels due to its relatively small size ( 244.3 Da). General 
formula of biotin derivatives and schematic representation of biotinylation are 
shown in the following figure. 
15 
 
 
Figure  12: Schematice representation of biotinylation reactive and general 
formula(on the left) and general formula of biotin derivatives(on the right)
2
 
  
 
Labeling proteins or nucleotides, namely biotinylation process, could be done 
both by chemical and enzymatic ways of which chemical ways are the most 
preferred.  There is a  biotinyl group, a spacer arm and a reactive group which is 
responsible for the attachment to target functional groups on proteins. Spacer arms 
function to link the biotin molecule to a reactive group which interacts with 
certain functional groups on the amino acids of the target protein
3
.  
There exists a wide range of biotinylation reagents with different reactive groups 
commercially available. Most common reactive groups with their respective 
targets on proteins can be listed as follows
3
: 
 
 N-hydroxysuccinimide(NHS) and sulfo-N-hydroxysuccinimide (Sulfo-
NHS)- primary amines  
 Primary amines in combination with EDC-carboxyls 
 Hyrdrazines and alkoxyamines- glycoproteins  
 Maleimide, iodoacetyl gropus or pyridyl disulfides- sulfhydyrls 
 
Enzyme labels are significantly larger than biotin and require the addition of a 
substrate to generate a chemiluminescent, chromogenic, or fluorescent signal that 
can be detected by different approaches. Due to multiple types of signal output, 
signal amplification and the wide selection of enzyme-labeled products(especially 
antibodies) enzymes are preferred. Horseradish peroxidase (HRP), alkaline 
phosphatase (AP), glucose oxidase and β-galactosidase are commonly used 
16 
 
enzymes for labeling. Enzyme probes can be used via conjugation to antibodies, 
streptavidin or other target proteins by multiple mechanisms, including 
glutaraldehyde, reductive amination following periodate oxidation of sugars to 
reactive aldehydes or by using heterobifunctional crosslinkers such as Sulfo-
SMCC
3
. 
 
1.2.5 Radioactive labeling  
 
For radioactive labeling, the protein should be purified. Biological activity is 
affected from radiolysis due to effects in 3D structure and radicalic reactions. 
3
H, 
125
I, 
35
S, 
32
P, 
14
C are some important radioactive isotopes. There is only isotope 
difference between natural amino acids and those labeled with 
3
H and 
14
C. Half–
life of 
32
P is rather short. Labeling with this isotope is significant in metabolic 
regulation studies. Labeling with 
35
S is important in research of newly synthesized 
proteins
2
. 
 
1.2.6  Novel methods  
 
A recently developed ligand-directed tosyl (LDT) based technique allows 
attachment of several synthetic probes to proteins in living cells
81
.This is an 
advantageous method in terms of its simplicity and versatility
82
.  During the 
labeling reaction, a nucleophile from the target surface attacks the probe’s 
electrophilic center to form a covalent adduct, with the release of the ligand that is 
attached to the other side of the tosyl leaving group. A series of 
benzenesulfonamide containing probes designed for three different detection 
modalities (fluorophore, biotin affinity tag or 19F NMR probe) were synthesized 
in order to demonstrate the efficiency of this technique. The fluorescent probes 
were efficient in labeling carbonic anhydrase II (CAII) in test tubes, in human red 
blood cells (RBCs) and in living animals
83
. 
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a)A disulfide linker cleaved by DTT and subsequently modified by probe-
containing electrophiles such as iodoacetylated dansyl group b)Hydrazone linker 
converted to oxime with the restoration of enzyme activity c) LDT chemistry. P: 
probe, L: ligand, Nu: nucleophile. Picture adapted from reference 82 with 
permission. Copyright © 2012 Copyright Clearance Center, Inc. 
 
HaloTag is a new protein tagging system that is applicable to be linked onto a 
single genetic fusion either in solutions or in living cells or in chemically fixed 
cells. HaloTag is a protein which is modified haloalkane dehalogenase designed to 
covalently bind to synthetic ligands (Halo-Tag ligands). The synthetic ligands are 
based on a chloroalkane linker attached to avariety of useful molecules, such as 
fluorescent dyes, solid surfaces. A highly specific covalent bond formation occurs 
between the protein tag and the chloroalkane linker. This system is utilized for 
cell imaging and protein immobilization
84
.  
 
Figure  13: Some recently developed ligand-directed protein labeling strategies 
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Development of affinity probes for protein labeling based on an epoxide reactive 
group has been achieved. Epoxide functionality possesses the special combination 
of stability and reactivity which makes it stable toward proteins in solution but 
reactive on the protein surface outside the active site (proximity-induced 
reactivity). Highly efficient and selective labeling of purified HCA II (human 
carbonic anhydrase II) was achieved by this way
85
. 
 
 
 
Figure  14: A concept of an affinity labeling probe. Labeling may occur either at 
the active site (activity site affinity label) or outside the active site (general 
affinity label). FG: functional group. Picture adapted with permission from 
reference 85. Copyright © 2003, American Chemical Society 
 
Based on the ‘’turn-on’’ fluorescence intensity phenomena, there exists a 
photoactive yellow protein labeling (PYP) system in the literature. Photoactive 
yellow protein is isolated from purple bacteria. In this method, fluorescent probes 
have been develeoped which begin to give emission when attached to PYP which 
makes a good probe for protein detection and applicable for research to determine 
biological functions
86
.   
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Figure  15: Principle of fluorogenic labeling system based on PYP.Picture 
adapted from reference 86 with permission. Copyright © 2009, American 
Chemical Society 
There exists many other materials available to be used as probes for protein 
detection or startegies for protein labeling in the literature, each having its own 
advantages and disadvantages
87-93
. 
 
1.3 BODIPY Dyes  
 
Boradiazaindacene (BODIPY) dyes have gained popularity among the other 
known fluorescent dyes within the last decade. They have been the choice of 
many chemists, biochemists and other scientists. Kreuzer and Treibs were first to 
synthesize BODIPY dyes in 1968
94
. These dyes have been developed and 
proposed as useful in many areas such as photodynamic therapy, light harvesting 
systems, energy transfer cassettes, molecular logic gates and sensitizers for solar 
cells. 
 
BODIPY dyes offer many advantegous properties. Firstly, they have high molar 
extinction coefficients. Depending on the structure and environmental conditions, 
they offer strong absorption and fluorescence spectra in the visible region together 
with high quantum yields
95
. Secondly, they are relatively stable dyes, not sensitive 
to solvent polarity or pH of the solution and could be soluble in both organic and 
inorganic solvents depending on the functionalization of the available positions. 
Furthermore, BODIPY molecule has 8 positions available for functionalization 
which brings out new members together with different photophysical properties. 
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Substitution on 1
th
, 3
th
, 5
th
, 7
th 
positions by condensation reactions gives out long 
wavelength absorbing and emitting derivatives
96.97
. Bare BODIPY core has an 
absorption value around 500 nm. Functionalization from meso does not offer 
significant and interesting change in photophysical properties of the dye
98
. 
Position numbering of BODIPY core  is given in the following figure. 8
th
 position 
has a special name ‘’meso’’. α and β terms could also sometimes be useful.  
 
 
Figure  16: Position numbering of BODIPY 
 
2
th
 and 6
th
 positions have relatively less positive charge than the others and 
therefore more prone to electrophilic attacks. Halogenation on these positions is 
important in Suzuki and Sonogashira coupling reactions. On the other hand, 
halogenations, due to heavy atom effect, decreases the quantum yield. Both mono 
and di-halogenations are possible and the spectrum generally shifts to red region 
when the dyes are halogenated
98
. 1
th
, 3
th
, 5
th
, 7
th
 positions can also be 
functionalized by Knoavanagel reactions. Since these methlys are acidic, 
condensation is possible with different aldehydes. Derivatization of BODIPY dyes 
still continues all over the world by many research groups such as Akkaya, Ziessel 
and Burgess.  
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1.3.1 Applications of BODIPY dyes  
 
BODIPY dyes have found many areas of application due to offering many 
chemical and photophysical properties. Photosensitizers for solar energy 
conversion
99 
, through-bond (Dexter type) and through-space (Förster type) 
energy transfer cassettes
100,101 
are some of them. 
 
Photodynamic therapy(PDT) is a significant application area of BODIPY dyes 
which is a novel alternative treatment way for cancer. In PDT, e photosensitizer 
and a near-IR light source is used. These cause the production of singlet oxygen 
from molecular oxygen and since singlet oxygen is fatal to cancer tissue, the 
treatment is achieved. Since the skin tolerates between 650-800 nm, wavelength 
of light used is in this region. There is a study of Akkaya et al. about this subject 
in the literature
102
. A PDT agent were synthesized which can produce singlet 
oxygen when treated with 660 nm light. The molecule could also detect aciditiy 
and concentration of Na
+
 inside the cell and is able to target the cancer tissue. The 
study is represented in figure 17: 
 
Figure  17: Photodynamic therapy agent and AND logic gate by Akkaya et al. 
Copyright © 2009 American Chemical Society. Adapted with permission 
 
Light scattering is reduced at longer wavelengths; therefore fluorophores emitting 
beyond 650 nm are good agents for biological sensing. Two examples of red-
22 
 
emitting BODIPY dyes developped by Akkaya et al. are given in the following 
figure, namely bis(2-pyridyl)-substituted boratriazaindacene (on the left)
103 
and a 
fluorescent chemosensor for anions (on the right)
104
. 
 
 
                          
 
   Figure  18: Examples of red-emitting BODIPY dyes 
                        
                             
Protein labeling was one of the first applications of BODIPY dyes due to high 
quantum yields and photostabilities
105
. 
Figure 19 shows two examples from the literature. First one was published in 
Org.Biomol.Chem
106  
(on the left), the other was published in 
Angew.Chem.Int.Ed.
107  
(on the right) which are BODIPY dyes for protein 
labeling. 
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Figure  19: Literature examples of BODIPY dyes for protein labeling 
 
1.4 Fluorescence Phenomenon 
 
Electrons move to a higher electronic level (Sn, n>0) which is also known as 
‘’excited state’’ from their ground state (S0) when molecules are irradiated with 
light. The excited electron returns to its ground state via some mechanisms. The 
Perrin-Jablonski Diagram  ( Figure  ) is useful for visualizing possibilities of the 
processes that can occur after excitation. S0 is the lowest electronic state, S1, S2,.. 
are singlet electronic states. T1, T2.. are triplet excited states.    Lateral lines 
denoted as thinner than those standing for electronic states are vibrational levels. 
The excited electron firstly goes to S1 (the lowest electronic state) by scattering 
some of its energy which is called as ‘’internal conversion’’. For movement to S0 
from S1, there are some possibilities
108
. Turning back to ground state with 
emission of photon is ‘’fluorescence’’ which is the most significant of all the 
mechanisms.  Non-radiative dissipation of energy as heat is another way. 
Collisional quenching is another case in which excited molecules transfer their 
energy to nearby moelcules. Transition from a singlet state to a triplet state T1 is 
the last possibility called as ‘’internal conversion’’. The electron is then de-
excited to the ground state from the excited triplet state which is namely 
‘’phosphorescence’’ 108.  
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Figure  20: Jablonski diagram 
 
As it is seen on the Jablonski Diagram, emitted light has lower energy than the 
absorbed light and hence it has higher wavelength than that of the absorbed light. 
In other words, the emission spectrum of the fluorophore is red-shifted to a higher 
wavelength. Fluorophore is a chromophore emitting light.  
 
Figure  21: Simple representation of Stokes' shift 
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The red-shift which was firstly observed in 1852 by Sir George Stokes is known 
as ‘’Stokes’ shift’’ 109. The main reason for Stokes’ shift is the rapid decay of 
electron to the lowest vibrational level of S1. Solvent effects, complex formation, 
reactions at the excited state and energy transfer are the other causes of Stokes’ 
shift
110
. 
          
1.4.1 Photoinduced Electron Transfer (PeT) 
 
Photoinduced electron transfer (PeT) is a signalling case in which emission is 
either quenched or enhanced, encountered in fluorophore-spacer-receptor 
systems
111
. In figure 22, mechanism of PeT is given. The highest occupied 
molecular orbital (HOMO) of the receptor is between the the lowest unoccupied 
molecular orbital (LUMO) and the highest occupied molecular orbital (HOMO) of 
the fluorophore in the figure. The receptor also contains an electron rich group. 
One of the electrons of the fluorophore is in the excited state due to irradiation of 
light. An electron from HOMO of the receptor transfers to the HOMO of the 
fluorophore and pairs with the single electron in HOMO of it. This situation 
prevents returning of the excited electron of flurophore from LUMO to HOMO 
and as a result, the fluorescence is ‘quenched’. On the other hand, if an analyte is 
present in the medium to stabilize the receptor, the energy level of its HOMO is 
lowered and it can not transfer its electron to HOMO of the fluorophore. 
Consequently, strong fluorescence is observed. 
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Figure  22: Reprentation of PeT working principle 
 
 
 
Figure  23: Representation of reverse PeT working principle 
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There also exists reverse PeT (oxidative PeT) mechanism. This event occurs if the 
receptor includes electron withdrawing group
112
. If there is no analyte in the 
medium, the electron in LUMO returns to HOMO and strong fluorescence is 
observed. However, in the presence of an analyte binding, HOMO of the receptor 
decreases and the electron in LUMO of the fluorophore is transferred to LUMO of 
the receptor and the result is weak fluorescence. In other words, fluorescence is 
quenched as a result of the process known as ‘’reverse PeT’’ or ‘’oxidative PeT’’ 
which is summarized in the figure 23.  
 
1.4.2 Internal Charge Transfer  (ICT) 
 
In this phenomenon, there exist a fluorophore and a receptor without a spacer 
between them. The fluorophore has an acceptor part which is electron poor and a 
donor part which is electron rich. Excitation of such a fluorophore ends up with 
electron redistribution and creation of a dipole which result in electron donation 
from donor to acceptor
112
. 
The receptor, existing as a part of the Π-electron system of the fluorophore can be 
either an electron donating or electron accepting group. In the first case, consider 
an electron donating receptor such as an amino acid. When a cation is added to the 
medium, the excited state will be more destabilized as compared to the ground 
state and this will cause an increase in the energy gap between the excited state 
and the ground state. This scenerio means that the electron donating ability of the 
receptor decreases as a cation is present in the environment and the overall result 
is a ‘’blue shift’’ in the absorbance spectrum. In the second case, the receptor is an 
electron acceptor such as a carbonyl and the presence of a cation will enhance the 
electron withdrawing capacity of it. The excited state will be more stabilized as 
compared to the ground state and energygap will decrease causing a ‘’red shift’’ 
in the absorbance spectrum. The IcT phenomenon is explained in figure 24. 
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Figure  24: Schematic representation of ICT working principle 
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CHAPTER 2 
 
EXPERIMENTAL 
 
2.1 General 
 
Chemical compounds and solvents were obtained from Sigma-Aldrich and were 
used without further purification.  Thin layer chromatography to monitor reactions 
were performed by using  Merck TLC Silica gel 60 F254. In addition, Merck Silica 
gel 60 (particle size: 0.040-0.063 mm, 230-400 mesh ASTM) was used as the 
silica gel for column chromotography.  
 
1
H NMR and 
13
C NMR spectra were recorded  on the instrument Bruker DPX-400 
(operating at 400 MHz for 1H NMR and 100 MHz for 13C-NMR) at room 
temperature in CDCl3 and DMSO-d6  with tetramethylsilane (TMS) as internal 
standard. Coupling constants (J values) are reported in Hz and chemical shifts are 
given in parts per million (ppm). Splitting patterns are designated as s(singlet), d 
(doublet), t(triplet), q(quartet), m(multiplet), and p(pentet). 
 
Agilent Technologies 6530 Accurate-Mass Q-TOF LC/MS instrument was used 
to collect mass spectra data at Bilkent University, UNAM. A Varian Cary-100 
spectrophotometer was used to record absorption spectra. Furthermore, to obtain 
emission spectra, a Varian Eclipse Spectrofluoremeter instrument was used at 
Bilkent University, UNAM.  
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2.2 Synthesis Scheme 
 
 
             
 
       
Figure  25: Synthesis Scheme 
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2.3 Syntheses  
 
Three nitroolefin functionalized BODIPY dyes have been synthesized as potential 
protein labeling agents. Compound 1
113
 and compound 8
114
 were synthesized 
according to the literature.  
2.3.1. Synthesis of Compound 2  
 
4-(hydroxymethyl) benzaldehyde (0.5 g, 3.68mmol, 1 equiv.) was dissolved in 
400 mL Ar-degassed DCM in a 1 L round bottom flask. 2,4-dimethylpyrrole (0.83 
mL, 769.5 mg, 2.2 equiv.) was added. This was followed by the addition of 1-2 
drops of TFA. The mixture was stirred about 3 hr at room temperature. After TLC 
showed no starting material, p-chloroanil (903.93 mg, 1.1 equiv.) was poured into 
the reaction vessel. After 1 hr stirring, 6 mL TEA was added dropwise to the 
solution over a period of 5 min. The color turned out to be brown and it was 
stirred for an additional 30 min. Lastly, 6 mL BF3.OEt2 was added to the reaction 
in a dropwise manner over a period of 5 min, as well. The mixture was left to stir 
overnight at room temperature. Extraction was made with water (3x300 mL) and 
the organic layer was dried over anhydrous Na2SO4. After concentrating the 
organic layer in vacuo, it was purified by flash column chromotography with the 
eluant DCM. The product was obtained as red solid (380 mg, 29.2% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.51 (d, J = 7.8 Hz, 2H), 7.38 (d, 2H), 6.04 (s, J = 
31.5 Hz, 2H), 4.83 (s, 2H), 2.60 (s, J = 17.9 Hz, 6H), 1.46 (s, J = 51.7 Hz, 6H). 
 
13
C NMR (100 MHz, CDCl3) δC: 155.49, 143.08, 141.87, 141.54, 134.20, 128.18, 
127.38, 121.23, 64.78, 14.47. 
 
MS (TOF-ESI): m/z: Calcd:353.17 [M-H]
-
, Found:353.1673 [M-H]
-, ∆=-7.64 
ppm. 
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Figure  26: Synthesis of compound 2 
      
2.3.2 Synthesis of Compound 3  
 
Compound  2 (150 mg, 0.42 mmol) was dissolved in a minimum amount of Ar-
degassed DCM. Dess-Martin periodinane (359.2 mg, 0.84 mmol) was also 
dissolved in min. amount of Ar-degassed DCM and this was added dropwise to 
the previous one at 0
o
C. When the addition is completed, the reaction left to stir at 
room temperature for about 2 hrs. When TLC showed no starting material, the 
mixture was quenched with 20 mL sat’d Na2S2O3 solution. The organic layer was 
then washed with sat’d NaHCO3 solution (2x20 mL). It was lastly washed with 
water (2x20 mL) and dried over anhydrous Na2SO4. Flash column 
chromotography was performed to purify the organic layer by using 95:5/ 
DCM:MeOH as the eluant. The product was obtained as orange solid (90 mg, 
60% yield). 
 
1
H NMR (400 MHz, CDCl3) δH: 10.14 (s, J = 4.6 Hz, 1H), 8.04 (d, J = 6.2 Hz, 
2H), 7.53 (d, J = 8.0 Hz, 2H), 6.019 (s, 2H), 2.58 (s, 6H), 1.37 (s, 6H). 
 
13
C NMR (100 MHz, CDCl3) δC:191.43, 156.25, 142.75, 141.40, 139.68, 136.68, 
130.32, 129.15, 121.63, 121.60, 14.61, 14.50. 
 
MS (TOF-ESI): m/z: Calcd: 351.16 [M-H]
-
, Found:351.1548 [M-H]
-, ∆=-14.8      
ppm. 
33 
 
                   
                                    2      3 
 
Figure  27: Synthesis of compound 3 
      
2.3.3. Synthesis of Compound 4  
 
Compound 3 (80 mg, 0.23 mmol) was dissolved in 4 mL nitromethane. Oil bath 
was stabilized at 90
o
C. Solution was placed in oil bath and waited for 30 min. 
After that, a pinch of NH4OAc was added to the reaction vessel. The reaction was 
completed as monitored by TLC after 24 hr stirring. Nitromethane was evaporated 
in vacuo and flash column chromotography was performed to purify the product 
by using 95:5/DCM:MeOH as the eluant. The nitroolefin functionalized protein 
labeling agent was obtained as red crystals ( 45 mg, 49.5% yield). 
1
H NMR (400 MHz, d6-DMSO) δH: 8.35(d, J=18 Hz, 1H), 8.25 (d, J=14 Hz, 1H), 
8.1(d, J=8 Hz, 2H), 7.6(d, J=8 Hz, 2H), 6.2(s, 2H), 2.45(s, 6H), 1.4(s,6H) 
 
13
C NMR (100 MHz, d6-DMSO) δC: 156.23, 142.69, 139.66, 139.04, 138.02, 
137.86, 130.95, 130.83, 129.73, 129.45, 121.60, 14.62, 14.57. 
 
MS(TOF-ESI): m/z: Calcd: 394.16[M-H]
-
, Found:394.1492 [M-H]
-,∆=-2,74 ppm. 
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Figure  28: Synthesis of compound 4 
                             
2.3.4. Synthesis of Compound 9 
 
3,4,5-tris(2-(2-(2-methoxyethoxy)ethoxy)benzaldehyde (500 mg, 0.85mmol) was 
mixed with 2,4-dimethylpyrrole (176  mg, 1.85 mmol) in 350 ml argon degassed 
dichloromethane (DCM). 1-2 drops of TFA was added followingly. The mixture 
was stirred at room temperature for about 3 hours. When TLC showed no starting 
material, p-chloranil (229.8 mg, 0.93 mmol) was added to the reaction and it was 
stirred for an additional hour.  Then, 7 ml Et3N was added to the mixture dropwise 
over a period of 5 min and the resulting  brown solution was stirred for 30 min. 
After that, 7 ml BF3•OEt2   was added dropwise over another period of 5 min to 
the reaction and the resulting mixture was allowed to stir overnight. The reaction 
mixture was washed with water (3×300 mL) and extracted into DCM. The organic 
layer was dried over anhydrous Na2SO4, concentrated in vacuo and the crude 
product was purified by flash column chromotography packed with silica gel by 
using 95:5/ DCM:MeOH as the eluant. The product was obtained as a waxy dark 
orange solid (370 mg, 54% yield).  
1
H NMR (400 MHz, CDCl3) δH: 6.55 (s, 2H), 5.99 (s, 2H), 4.22 (t, J= 4.97 Hz, 
2H), 4.12 (t, J= 4.72 Hz, 4H), 3.84 (t, J= 5.29 Hz, 6H), 3.51-3.76 (m, 25H), 3.38 
(s, 2H), 3.36 (s, 6H), 2.54 (s, 6H), 1.52 (s, 6H). 
 
13
C NMR (100 MHz, CDCl3) δC: 155.8, 153.7, 142.9, 141.1, 139.0, 131.1, 129.9, 
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121.1, 107.7, 2.7, 71.9, 71.9, 70.8, 70.7, 70.6, 70.5, 69.7, 69.2, 58.8, 29.6 14.4, 
14.2. 
MS (TOF-ESI): m/z: Calcd: 809.4286 [M-H]
-
, Found: 809.4306 [M-H]
-, ∆= 2.47 
ppm. 
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Figure  29: Synthesis of compound 9 
                                                                                                                                                                   
2.3.5. Synthesis of Compound 10  
 
0.5 mL POCl3 was added into anhydrous DMF (0.5 mL) dropwise in ice bath. 
Addition was done under N2. This mixture (pale yellow viscous liquid) was left to 
stir for 30 min at room temperature.  Compound 9 (405.215mg, 0.5 mmol) was 
dissolved in 25 mL DCE and then slowly introduced to the previous mixture. The 
resulting brown solution was stirred at 60
o
C
 
for 3 hr. 60
o
C is the critical 
temperature to get the mono-formylated product 10, side products could be 
obtained otherwise at higher temperatures. Then the reaction was cooled to room 
temperature and poured into ice-cold saturated NaHCO3 solution. Extraction was 
performed with DCM (2x50 mL) and the organic layer was dried over Na2SO4. 
The organic layer was concentrated in vacuo and purified by flash column 
chromotography with 98:2/DCM:MeOH as the eluant. Target compound 10 was 
obtained as orange crytals(185 mg, 93% yield).                          
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1
H NMR (400 MHz, CDCl3) δH: 9.98 (s,1H), 6.53 (s, 2H), 6.15 (s, 1H), 4.23 (d, 
J= 4.34 Hz, 2H), 4.12 (d, J= 4.29 Hz, 4H), 3.83 ( d, J= 4.81 Hz, 6H), 3.75-3.49 
(m, 25H), 3.37 (s, 2H), 3.34 (s, 6H), 2.80 (s, 3H), 2.59 (s, 3H), 1.78 (s, 3H), 1.57 
(s, 3H).  
13
C NMR (100 MHz, CDCl3) δC: 185.81, 161.64, 156.47, 154.02, 147.17, 143.07, 
142.68, 139.54, 133.98, 129.65, 128.89, 126.25, 123.92, 107.04, 72.76, 71.93, 
71.88, 70.84, 70.68, 70.62, 70.55, 70.53, 69.69, 69.32, 58.96, 14.76, 11.55. 
MS (TOF-ESI): m/z: Calcd: 837.4235 [M-H]
-
, Found: 837.4094 [M-H]
-
,                
∆=-16,83ppm 
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Figure  30: Synthesis of compound 10 
                                       
2.3.6. Synthesis of Compound 11 
 
Compound 10 (140 mg, 0.17 mmol) was dissolved in 2 mL nitromethane. This 
solution was stabilized at 90
 o
C in oil bath in 30 min. Then NH4OAc (1.28  mg, 
0.017 mmol) was added to the mixture. The reaction was stirred for 5 days. When 
TLC showed no starting material, nitromethane was removed in vacuo. Flash 
column chromotography packed with silica gel was used to purify the crude 
product by using 95:5/ DCM:MeOH as the eluant. Compound 11 was obtained as 
a wine-red waxy solid (43 mg, 28.6% yield).  
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1
H NMR (400 MHz, CDCl3) δH: 8.05 (d, J= 13.8 Hz, 1H), 7.37 (d, J= 13.63 Hz, 
1H9, 6.56 (s, 2H), 6.18 (s, 1H), 4.26 (t, J= 4.64 Hz, 2H), 4.14 (t, J= 4.52 Hz, 4H), 
3.86 (t, J=5.15Hz, 6H), 3.52- 3.76 (m, 25H), 3.40 (s, 2H), 3.37 (s, 6H), 2.72 (s, 
3H), 2.63 (s, 3H), 1.64 (s, 3H), 1.59 (s, 3H).  
13
C NMR (100 MHz, CDCl3) δC: 161.54, 154.23, 154.03, 147.18, 147.22, 140.16, 
139.65, 134.60, 133.71, 130.71, 130.62, 128.89, 128.84, 123.93, 120.03, 107.41, 
72.81,71.96, 71.90, 70.86, 70.71, 70.68, 70.58, 70.56, 69.71, 69.36, 65.30, 59.01, 
29.67, 14.72, 12.85,11.09. 
MS (TOF-ESI): m/z: Calcd: 880.7612 [M-H]
-
, Found: 880.4134 [M-H]
-, ∆= -2.09 
ppm. 
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Figure  31: Synthesis of compound 11 
                       
2.3.7. Synthesis of Compound 12 
 
3,4,5-tris(2-(2-(2-methoxyethoxy)ethoxy)benzaldehyde (1500 mg, 2,55mmol) was 
dissolved in 450 ml argon degassed dichloromethane (DCM). 3-ethyl-2,4-
dimethyl-pyrrole (528 mg, 5.61 mmol) was added. 1 drop of TFA was added to 
mixture followingly. It was stirred for about 3 hr.  Reaction was monitored by 
TLC and when it showed no starting material, p-chloranil (698,4 mg, 2.79 mmol) 
was added in one portion. After an additional 1 hr stirring, 8 ml Et3N was added to 
the mixture dropwise over a period of 5 min and the resulting  brown solution was 
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stirred for 30 min. Thereafter, 8 ml BF3•OEt2   was added dropwise over another 
period of 5 min to the reaction and the resulting mixture was left to stir overnight 
at room temperature. The resultant mixture was washed with water (3×400 mL) 
and extracted into DCM. The organic layer was dried over anhydrous Na2SO4, 
concentrated in vacuo and the crude product was purified by flash column 
chromotography packed with silica gel by using 95:5/ DCM:MeOH as the eluant. 
The product was obtained as a waxy dark orange solid (1034 mg , 46.7% yield).  
1
H NMR (400 MHz, CDCl3) δH: 6.55 (s, J = 1.2 Hz, 2H), 4.24 (t, J = 7.4 Hz, 2H), 
4.12 (t, J = 4.5 Hz, 4H), 3.85 (t, J = 4.7 Hz, 6H), 3.78 – 3.47 (m, 24H), 3.40 – 
3.31 (m, 8H), 2.53 (s, 6H), 2.32 (q, J = 7.4 Hz, 4H), 1.42 (s, 6H), 1.00 (t, J = 7.35 
Hz, 6H). 
 
13
C NMR (100 MHz, CDCl3) δC: 153.79, 153.61, 139.66, 136.25, 132.74, 132.72, 
72.70, 71.91, 70.86, 70.71, 70.64, 70.55, 69.73, 69.18, 59.01, 58.98, 17.06, 14.59, 
12.47, 11.61 
 
MS (TOF-ESI): m/z: Calcd:865.49 [M-H]
-
, Found: 865.4904 [M-H]
-, ∆= -4.05       
ppm. 
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Figure  32: Synthesis of compound 12 
                        
2.3.8. Synthesis of Compound 13 
 
2,8-diethyl-5,5-difluoro-1,3,7,9-tetramethyl-10-(3,4,5-tris(2-(2-(2-
methoxyethoxy)ethoxy)ethoxy)phenyl)-5H-dipyrrolo[1,2-c:2',1'-
f][1,3,2]diazaborinin-4-ium-5-uide (Compound 12) (400 mg, 0.46 mmol) was 
dissolved in 18 mL, Ar-degassed THF in 100 mL round bottom flask. DDQ(420 
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mg, 0.54 mmol) was dissolved in 6 mL, Ar-degassed THF and 0.16 mL distilled 
water was added. This mixture was added dropwise to the previous one at 0
o
C 
under Ar. When the addition is completed, the reaction was left to stir for 3 days. 
When TLC showed no starting material, the resultant mixture was purified by 
flash column chromotography filled with silica gel. 95:5/ EtOAc:MeOH was used 
as eluant. Product was obtained as red solid(350 mg, 86% yield). 
1
H NMR (400 MHz, CDCl3) δH: 10.38 (s, 1H), 6.56 (s, 2H), 4.26 (s, 2H), 4.14 (s, 
4H), 3.80-3.51 (m, 30H), 3.44 – 3.30 (m, 9H), 2.72 (s, 2H), 2.61(s, 3H), 2.36 
(s,2H), 1.55 (s,3H), 1.41 (s, 3H), 1.05 (s, 6H). 
 
13
C NMR (100 MHz, CDCl3) δC: 213.74, 185.97, 166.16, 153.90, 143.72, 141.50, 
139.87, 139.23, 137.71, 137.03, 135.60, 134.33, 132.05, 129.58, 107.47, 77.37, 
77.05, 76.73, 72.73, 71.90, 71.86, 70.80, 70.61, 70.59, 70.50, 70.46, 69.66, 69.23, 
59.02, 59.01, 58.98, 17.59, 17.12, 14.34, 14.02, 13.68, 12.26, 10.44. 
MS (TOF-ESI): m/z: Calcd: 879.47 [M-H]
-
, Found:879.468 [M-H]
-, ∆= -2.52        
ppm. 
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Figure  33: Synthesis of compound 13 
                                             
2.3.9 Synthesis of Compound 14  
 
2,8-diethyl-5,5-difluoro-3-formyl-1,7,9-trimethyl-10-(3,4,5-tris(2-(2-(2-
methoxyethoxy)ethoxy)ethoxy)phenyl)-5H-dipyrrolo[1,2-c:2',1'-
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f][1,3,2]diazaborinin-4-ium-5-uide (Compound 13) (340 mg, 0.39 mmol) was 
dissolved in 5 ml nitromethane. It was placed in an oil bath at 90
o
C. A pinch of 
NH4OAc was added. The reaction was stirred at this temperature for 3 hr. Product 
was obtained as violet-purple solid (90 mg, 25.2% yield). 
1
H NMR (400 MHz, CDCl3) δH: 8.36 (d, J = 13.7 Hz, 1H), 7.84 (d, J = 13.8 Hz, 
1H), 6.55 (s, 2H), 4.29 – 4.17 (m, 2H), 4.17 – 4.01 (m, 4H), 3.90 – 3.82 (m, 6H), 
3.82 – 3.33 (m, 34H), 2.72 – 2.32 (m, 7H), 2.08 – 1.68 (m, 1H), 1.50 (s, 3H), 1.46 
(d, J = 26.5 Hz, 6H), 1.07 (m, J = 19.8, 7.5 Hz, 6H). 
 
13
C NMR (100 MHz, CDCl3) δC:
  
165.16, 153.95, 143.06, 140.18, 139.36, 137.86, 
137.81, 137.76,  137.51, 137.47, 136.35,  135.43, 135.09,  133.94, 129.50, 127.51, 
107.56, 77.37, 77.06, 76.74, 72.76, 71.95, 71.89, 70.85, 70.70, 70.65,  70.56, 
69.70, 69.27, 59.03, 59.00. 
 
 
MS (TOF-ESI): m/z: Calcd:  922.48  [M-Na]
+
, Found: 946.47   [M-Na]
+, ∆= -8.73    
ppm. 
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                                   Figure  34: Synthesis of compound 14 
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CHAPTER 3 
 
RESULTS AND DISCUSSION 
 
3.1.General Perspective 
 
Starting with studies of non-covalent interactions between host and guest 
molecules, the field of supramolecular chemistry has enlarged to include self-
assembly, molecular recognition systems, self-organization, molecular devices 
and many others. Proteins, comprising one of the major classes of biomolecules of 
life, has to be tracked in order to observe their mechanisms, determination of 
turnover numbers of enzymes and sometimes even for targeting a tumor tissue. As 
a very significant member of supramolecular chemistry field, BODIPY dyes are 
functionalized and derivatized to be engaged in various applications thanks to 
their high absorption coefficients, strong fluorescence, ease of synthesis, stability, 
etc. In addition to solar cells, photodynamic therapy, molecular logic gates, 
energy transfer cassettes and some others, protein labeling is a good area for the 
use of BODIPY dyes. 
 Akkaya et al. have recorded significant work in the mentioned areas with 
production of novel BODIPYs so far. In this study, we enriched our work and 
have brought three nitroolefin functionalized BODIPY dyes for protein labeling in 
our records.  
3.2. Design and Properties of target dyes  
 
BODIPY core has 8 positions available for functionalization as shown in figure 
35. 
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Figure  35: 8 positions of BODIPY dyes available for modification 
 
In this study, we have designed and synthesized three different nitroolefin 
subsituted BODIPY dyes, namely compound 4 (dye 1), compound 11 (dye 2) and 
compound 14 (dye 3) as shown in the figure 36. 
 
 
Figure  36: Target protein labeling agents 
 
On compound 4, nitroolefin group is on top of a benzene ring on position 8. 
Compound 11 has its 2
nd
 position functionalized with the nitroolefin group and 
compound 14 has been incorporated with the nitroolefin from its 3
rd
 position. 
These nitroolefin groups are good Micheal acceptors. Esters, nitriles, nitro groups, 
α,β-unsatırated ketones, etc. act as good Micheal acceptors existing in the 
literature
115,116
. They are good candidates for nucleophilic attack. 
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Figure  37: Examples of Micheal acceptors 
                              
Table 1 summarizes photophysical properties of the dyes. The absorption maxima 
of compound 4, 11 and 14 are 503 nm, 525 nm and 570 nm respectively. Molar 
extinction coefficients (max  ) are calculated from Beer-Lambert Law. max  were 
found as 105,694 cm
-1
M
-1
 , 32,000   cm
-1
M
-1
 and 38,918 cm
-1
M
-1 
for compound 4, 
11 and 14 respectively.  
                                                   
Compound  abs (nm) em (nm) f
* max  (cm
-1
M
-1
) 
         4        503         515       0.067     105,694 
        11        525        540       0.056     58,500 
        14        570        530       0.019     38,918 
Table 1: Photophysical properties of dyes.* relative quantum yields. Reference 
dye: Rhodamine 6G in water (f :0.95) 
 
3.2.1 Synthesis and Characterization  
 
The synthesis of compound 4 started with reaction of 2,4-dimethylpyrrole and 4-
(hydroxymethly) benzaldehyde. Then the –OH group was oxidized to the 
aldehyde form with Dess-Martin periodinane reagent via Dess-Martin oxidation 
reaction
117
. As the third step, NH4OAc (ammonium acetate) was used as the 
catalyst and by using nitromethane at 90
0
C, nitroolefin functionalized form was 
obtained declared as “dye 1’’. Our second design was compound 11 which 
included TEG groups to enhance its water solubility. Compound 9 was formylated 
on the 2
nd
 position via Vilsmeier-Haack reaction
117
.   2-formyl BODIPY was then 
subsequently nitroolefinated to give the so called ‘’dye 2’’. The same procedure 
44 
 
was conducted for the synthesis of compound 14, in other words, ‘’dye 3’’. This 
molecule also includes TEG groups but it was synthesized by using 2,4-dimethyl-
3-ethyl pyrrole making it a little different from the previous BODIPY. 
Consequently, dye 2 & dye 3 are more soluble in water as compared to dye 1. For 
characterization, 
1
H-NMR and 
13
C-NMR spectra were recorded and results were 
also supported by mass spectrum as presented in appendix part. For dye 1, 
DMSO-d6 was used as NMR solvent. In order to prove the reaction of dyes with 
thiol including groups, mercaptoethanol, the simplest of all, was chosen. Figure 
38 shows a comparison of aromatic region of 
1
H-NMR of compound 4 and that of 
its conjugated form with mercaptoethanol. As it is clear, trans protons are 
removed due to the breakage of the double bonds. The same is given in figure 39 
for compound 11 that shows the removal of trans protons around 8.0 ppm. 
 
Figure  38: Comparison of aromatic regions of 
1
H-NMR of compound 4 and that 
of  its conjugated form with mercaptoethanol 
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Figure  39: Comparison of aromatic regions of 
1
H-NMR of compound 11 and 
that of its conjugated form with mercaptoethanol  
 
3.3 Reactions with cysteine & spectroscopic data  
 
First one of the three BODIPY dyes of this study, compound 4, is the simplest but 
the most interesting protein labeling agent that we propose. Nitroolefin group 
bonded to the benzene ring on the meso position of our BODIPY makes it possess 
significant properties. Above everyhting, this is a ‘’Turn-on’’ agent showing 
excellent fluorometric changes upon reaction with thiol moities. It gives very fast 
reaction, perfectly bright color and strong signalling after the aforementioned 
event. Thanks to being such a small molecule and not containing any bulky 
groups, there is no possibility of steric hinderence to prevent desired reactions. On 
the other hand, since it does not contain any water-soluble units, it requires mostly 
organic solvents to dissolve in and therefore it may need some water-solubilising 
units to be a better candidate in biological applications. As a suggestion, its 
distyryl form could be synthesized via Knoavanagel condensation reaction with 
3,4,5-(trihydroxybenzaldehyde) to increase the number of TEG units and increase 
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water solubility. To test spectroscopic changes after the nucleophilic attack of a 
thiol group, cysteine solutions were prepared and reacted with our dye 1 to collect 
absorbance and emission spectra. 1 µM solutions of compound 4 were used in the 
measurements prepared in 1x PBS:DMSO (5:95, V/V, pH:7.4 at 25
0
C). Figure 40 
shows UV-VIS absorbance spectra of dye 1. As it is seen, the compound itself has 
an absorption band at 503 nm and there is no remarkable change neither in 
absorbance intensity nor in the wavelength of absorbance no matter how much 
cysteine is added to the system. The reason is that, the benzene ring on the 
BODIPY core is positioned as perpendicular to the whole system as its 
architecture suggests and therefore it does not correspond to the Π-conjugation 
system of the compound as shown  in the figure 41. Consequently, there is no ICT 
and ICT blocking phenomenon in this process and there observed no colorimetric 
changes. 
 
 
 
Figure  40: UV-VIS absorption spectra of compound 4 in 1x PBS:DMSO (5:95, 
V/V, pH:7.4 at 25
0
C) 
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Figure  41: Representation of the perpendicular stand of benzene ring on meso 
poisiton of BODIPY 
 
           
 
Figure  42: Fluorescence spectra of compound 4 in 1x PBS:DMSO (5:95, V/V, 
pH:7.4 at 25
0
C) upon increased L-Cys addition 
 
Contrary to absorbance results, fluorometric changes were expected in this study. 
Figure 42 shows the fluorescence spectra recorded in the same conditions as 
absorbance spectra were done. Excitation wavelength was chosen as 490 nm and 
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the slit width was 5-2.5. Because the reaction was very fast and effective, it 
became saturated so rapidly that it was difficult to obtain proper spectra with slit 
widths 5-5. Equivalents greater than 100 were not even collected in the case of 5-
2.5 slit width because there was again sudden saturation due to the speed of the 
conjugation. As depicted in figure 42 , fluorescence intensity of dye 1  gradually 
increases upto 20-fold of its first value upon addition of increased L-Cys 
concentrations (0-100 equiv). This outcome is due to the interruption of PeT 
process and successful increase in fluorescence intensity is proved making it 
possible to declare our dye 1 as a ‘’turn-on’’ labeling agent.  
  
                      
Figure  43: Representation of blocking PeT process on compound 4 upon reaction 
with a thiol and turn-on fluorescence  
 
 
Figure  44: Compound 4 and its L-cysteine conjugated form respectively under 
ambient light (on the left), under UV-light (on the right) 
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Figure 43 shows the mechanism of emission increase during addition of a thiol 
group. The BODIPY core is the electron donor (fluorophore) and the meso 
substituted part is the electron acceptor. As a thiol including group is present in 
the medium, there appears Micheal 1,4-addition
  
product and the double bond is 
broken. This is the interruption of electron donation from the fluorophore to the 
acceptor which is accompanied by bright signalling.  
Compound 4 is normally orange, but it turns out to be yellow upon addition of L-
cysteine which is shown in the figure 44. The picture taken under UV light shows 
that the dye has no emission initially and it turns on in the presence of L-cysteine.  
Compound 11, the second labeling agent, has a gallic acid derived unit at its meso 
position. It offers several properties. Firstly, ethylene glycolic units functionalized 
from the phenolic hydroxyls enhance the compound’s water-solubility. Ability to 
readily dissolve in mostly water makes the agent attract more attention because of 
ease of use in bio-applications. Secondly, the gallic acid derived unit on the meso 
position of the compound can stop PeT when it is attached to BODIPY core which 
is electron-poor due to conjugation with a nitroolefin unit and consequently, there 
observed is a weak fluorescence. Reaction of this molecule with a thiol group was 
anticipated to disrupt the Π conjugation of the system and cause a blue shift in the 
absorbance spectrum. In other words, blocking the ICT process was expected. 
Upon nucleophilic attack of the thiol moity, disruption of PeT process and 
observation of strong fluorescence was another expectation.    
Dye 2 had an absorption band located at 525 nm which decreased upon addition 
of L-Cys and a new one at 510 nm started to appear. There was a total of 15 nm 
blue shift in the spectra and an isosbestic point at 518 nm was present. 
Absorbance spectra is given in figure 45. This cysteine-triggered blue shift was 
the proof of disruption of ICT process. Furthermore, compound 11 (dye 2) is not 
fluorescent with Φf=0.056 as it is seen on its emission spectra in figure 46. As 
seen from figure 46, fluorescence intensity of the dye gradually increases upto 20-
fold of its first value upon addition of increased Cys concentrations (0-400 equiv.) 
λex was 500 nm at 25 °C. This is attributed to the blocking of PeT process in the 
presence of the reaction with the thiol group in the medium  
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Figure  45: UV-VIS absorption spectra of compound 11 (5 µM) in 50 mM 
HEPES:CH3CN (80:20, v/v, pH=7.2, at 25
0
C)  upon increased L-Cys 
concentrations  
 
Figure  46: Emission spectra of compound 11 in 50 mM HEPES:CH3CN (80:20, 
v/v, pH=7.2, at 25
0
C)  upon increased Cys addition  
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Dye 2 is red in color and when it is reacted with L-cysteine, it color turns out to be 
orange as shown in figure 47. The color and emission differences of the 
conjugated and the unconjugated dyes are also shown under UV light. The 
fluorescence intensity is also observed easily in the Picture taken under UV light.  
 
              
Figure  47: Compound 11 and its L-cysteine conjugated form respectively under 
ambient light (on the left), under UV-light (on the right) 
Third target, namely compound 14 or dye 3 is another proposed labeling agent. A 
very similar work was published
119
 this year in ChemComm as our work was in 
progress as shown in figure 48: 
      
Figure 48: A nitroolefin functionalized BODIPY chemodosimeter 
 
This BODIPY has a methyl (-CH3) on its meso position whereas ours has a gallic 
acid derivative with TEG groups. They used 1:1 HEPES:ACN solution for their 
measurements, but we used 80:20 HEPES:ACN (v/v) because our molecule’s 
water solubility is enhanced due to the TEG groups as compared to the one in this 
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article. Moreover, their BODIPY was for thiol sensing, ours is for protein labeling 
with superior solubility in inorganic environments.  
Figure 49 shows absorbance spectra of compound 14 (2.5 µM) in reaction with L-
L-cysteine with increasing concentrations between 0 mM-0.5 mM in 50 mM 
HEPES:ACN (80/20, v/v, pH:7.4 at 25 
0
C). Records began with the absence of 
cysteine and it went up to 200 equivalent L-cysteine. Dye 3 possesses an 
absorption band at 570 nm which declined with addition of Cys and a new one at 
527 nm started to appear. There was a total of 43 nm blue shift in the spectra and 
an isosbestic point at 550 nm was observed. Similar to those obtained for 
compound 11, this was a consequence of blocking the ICT process. Since NO2 is 
fit in perfect conjugation with the Π- electron system of the BODIPY core, this 
change was an expected one. In other words, there was a ‘’turn-off’’ process for 
ICT and we recorded a hypsochromic shift in absorption spectra. PeT process is 
also off at this stage and the overall result is both a colorimetric and a 
fluorometric change.  
Figure 50 shows the emission changes after L-Cys addition. Excitation is made at 
520 nm. As it is clear, there is about 20-fold increase in emission intensity with 
the addition of 200 equivalent Cys. Figure 51 shows the color differences of the 
blank dye and its conjugated form to L-cysteine both in ambient light and under 
UV light. Dye 3 is normally pink and it turns out to be yellow with cysteine. The 
birght emission is depicted in the picture, as well.  
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Figure  49: UV-VIS absorption spectra of compound 14 (2.5 µM) in 50 mM 
HEPES:ACN (80/20, v/v, pH:7.4 at 25 
0
C) upon increased L-Cys concentrations 
        
Figure  50: Fluorescence spectra of compound 14 in 50 mM HEPES:ACN 
(80/20, v/v, pH:7.4 at 25 
0
C) upon increased L-Cys concentration    
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Figure  51: Compound 14 and its L-cysteine conjugated form respectively under 
ambient light (on the left), under UV-light (on the right) 
 
3.4 Protein Labeling Studies & Spectroscopic Data 
 
 
Figure 52: Incubation for protein labeling (on top) & dialysis (on the bottom) 
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As the last step of the study, the dyes were used to label the proteins. Bovine 
Serum Albumin (BSA) was chosen as the sample protein. For conjugation of the 
dyes with proteins, the first step was to prepare a solution of them. For studying 
with compound 4, BSA was dissolved in PBS (1 mg/mL). BODIPY was added 
onto it as 50-fold molar excess in order to ensure the reaction. It was taken from a 
stock sloution prepared in DMSO. For studying with compound 11, BSA was 
again dissolved in buffer, HEPES was preferred. Assuming that this could be a 
slower reactionas compared to the previous one, 100-fold molar excess of dye 2 
was added from a stock solution in DMSO. The mixtures were protected from 
light, incubated overnight, and left on a nutating mixer at room temperature as 
depicted in the figure 52 on top. Then to remove excess BODIPY, we chose 
dialysis, which is a very simple method, instead of HPLC or other methods. For 
dialysis, a dialysis membrane with molecular weight cut off (MWCO) between  
12-6000 KDa was used. Mixture was put in the membrane and dialyzed for about 
12 hours. Compound 4 is 0.395 KDa, compound 11 is 0.881 KDa, compound 14 
is 0.923 KDa and BSA is 66 KDa (1Da is equal to 1 g/mol).  The logic behind this 
is very basic; particles with diameters smaller than that of the pores of the 
membrane escape from the membrane and those with bigger diameters stay inside 
and a bulk of solvent outside makes the process easier and faster. As the dialysis 
solvent is changed, one can remove the excess dye from the medium. The residue 
in the membrane is just the BODIPY-BSA conjugate which could be taken from 
the membrane and used in analysis.  
During dialysis, the outer solvent enters inside the membrane, the one inside goes 
off the membrane and an equilibrium is reached. During these dyanmics, inside 
conjugate is diluted. An amount of it is taken from inside the membrane and used 
in spectroscopic analysis. In order to determine the concentration of it, we firstly 
measure its absorbance and by comparison with a BODIPY solution with a known 
concentration, one can calculate the concentration of the conjugate from Beer-
Lambert Law. For compound 4 ( dye 1), as figure 53 shows, absorbance at 
maxiumum for a 1 µM dye is 0.0672, it is 0.0551 for the conjugate and  from the 
formula  A1/A2 = C1/C2  we find the concentration of the conjugated dye as 0.82 
µM. As it is shown on figure 54, emission at these concentrations has increased 
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from nearly zero to nearly 700 hunderds. (λex 490 nm at 25 °C, slit 5-2.5).This 
spectra is the proof of disruption of PeT as a result of conjugation of the dye to 
protein. 
Figure 55 shows the absorbance spectra for dye 2 and for BSA-dye 2 conjugate. 
For compound 11 (dye 2), absorbance at maxiumum for a 2 µM dye is 0.09862, it 
is 0.11304 for the conjugate and  from the formula  A1/A2 = C1/C2  we find the 
concentration of the conjugated dye as 2.8 µM. For these concentrations, 
emissions were also recorded as shown in figure 56 . As it is clear, emission has 
increased nearly to 500 from 80 ( λex 500 nm at 25 °C, slit 5-5). 8-fold increase is 
recorded in total.   
 
 
Figure 53: Absorbance spectra of dye 1 and BSA-dye 1 conjugate in 1x 
PBS:DMSO (5:95, V/V, pH:7.4 at 25
0
C) 
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Figure  54: Emission spectra of dye 1 and BSA-Dye 1 conjugate in 1x 
PBS:DMSO (5:95, V/V, pH:7.4 at 25
0
C) 
 
 
 
Figure  55: Absorbance spectra of dye 2 and BSA-Dye 2 conjugate in 50 mM 
HEPES:ACN (80/20, v/v, pH:7.4 at 25 
0
C 
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Figure  56: Fluorescence spectra of dye 2 and BSA-dye 2 conjugate in 50 mM 
HEPES:ACN (80/20, v/v, pH:7.4 at 25 
0
C 
 
Protein labeling study for compound 14 is the future work. According to the 
article in reference 118, instead of nitroolefin conjugation to BODIPY dye, there 
occurs elimination of nitroolefin upon addition of mercaptoethanol as shown in 
figure 57. Disruption of ICT is stil observed and emission intensity increases but 
the mechanism is different. Consequently, the same result may be obtained in our 
case, as well.  
 
 
Figure  57: Elimination of nitroolefin from reference 118 
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CHAPTER 4 
Conclusion 
 
In this study, we have synthesized three different nitroolefin functionalized 
BODIPY dyes for protein labeling. Their characterization were made 
successfully. Since thiol groups can make nucleophilic attack easily and 
nitroolefin groups are good Micheal acceptors available for a nucleophilic attack, 
a chemical bond between them is formed and fluorescence is increased making 
the conjugate highly bright. This is the logic behind our study and it makes our 
compounds available for protein labeling. Results show that compound 4 is the 
most efficient in terms of fluorescence, though it is not very soluble in water. 
Compound 11 and compound 14 have TEG groups and therefore they are 
enhanced in terms of water-solubility. Protein labeling agents generally bond to 
proteins either from N-terminus or C-terminus, we herein reported a connection 
from thiol groups of proteins. We also engineered BODIPYs, incorporating 
nitroolefins into them and developped a path for nitroolefin functionalization 
reactions.  
The study is a proof of principle work that basically shows the emission increase 
upon reaction of a nitroolefin with a thiol group based on blocking PeT and/or 
ICT phenomena. Our future work is expected to include protein labeling studies 
with compound 14 and to conduct cellular studies for all three compounds, as 
well. Our group is also expected to design and synthesize new protein labeling 
agents in the future.  
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APPENDIX  A 
 
NMR SPECTRA 
 
 
 
            Figure  58:  
1
H NMR spectrum of compound 2 
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     Figure  59: 
1
H NMR spectrum of compound 3 
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        Figure  60:
 1
H NMR spectrum of compound 4 
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Figure  61: 
1
H NMR spectrum of compound 9 
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              Figure  62: 
1
H NMR spectrum of compound 10 
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Figure  63:
 1
H NMR spectrum of compound 11 
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Figure  64: 
1
H NMR spectrum of compound 12 
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Figure  65: 
1
H NMR spectrum of compound 13 
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Figure  66: 
1
H NMR spectrum of compound 14 
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Figure  67:
 13
C NMR Spectrum of compound 2 
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Figure  68:
 13
C NMR Spectrum of compound 3 
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     Figure  69: 
13
C NMR Spectrum of compound 4 
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Figure  70:
 13
C NMR Spectrum of compound 9 
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Figure  71: 
13
C NMR Spectrum of compound 10 
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                   Figure  72:
 13
C NMR Spectrum of compound 11 
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Figure  73:
 13
C NMR Spectrum of compound 12 
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       Figure  74:
 13
C NMR Spectrum of compound 13 
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Figure  75:
 13
C NMR Spectrum of compound 14 
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APPENDIX B 
 
MASS SPECTRA 
 
 
 
    Figure  76: Mass spectrum of compound 2 
 
 
 
    Figure  77: Mass spectrum of compound 3 
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Figure  78: Mass spectrum of compound 4 
   
 
Figure  39: Mass spectrum of compound 9 
 
 
 
Figure  80: Mass spectrum of compound 10 
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Figure  40: Mass spectrum of compound 11 
 
   
 
 
Figure  82: Mass spectrum of compound 12 
 
 
Figure  83: Mass spectrum of compound 13 
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Figure  84: Mass spectrum of compound 14 
 
                                         
 
